Grifols reported EUR766.49M in Gross Profit on Sales for its fiscal quarter ending in December of 2024.





Gross Profit On Sales Change Date
Alaunos Therapeutics USD -1.13M 1.11M Sep/2024
Arca Biopharma 0 0 Mar/2025
aTyr Pharma USD 987.07K 797.07K Mar/2026
Capricor Therapeutics 11.13M 8.87M Dec/2024
Cara Therapeutics USD 2.57M 1.11M Mar/2025
GlaxoSmithKline GBP 5.75B 429M Mar/2026
Grifols EUR 766.49M 39.74M Dec/2024
Immunic 0 0 Mar/2025
Minerva Neurosciences -4.27M 26.79M Dec/2024
Nektar Therapeutics USD 21.81M 8.06M Dec/2025
Sangamo BioSciences -2.39M 1.09M Jun/2024
TherapeuticsMD USD 234K 79K Jun/2024